Oncolytics Biotech Stock Cycle Indicators Hilbert Transform Dominant Cycle Phase
ONCY Stock | USD 1.07 0.05 4.46% |
Symbol |
Indicator |
The minimum time period for execution of this function requires larger time horizon. Please increase the time horizon for this function. The output start index for this execution was zero with a total number of output elements of zero. The Hilbert Transform - Dominant Cycle Phase indicator shows inphase and quadrature components of Oncolytics Biotech price series in order to analyze variations of the instantaneous phase and amplitude.
Oncolytics Biotech Technical Analysis Modules
Most technical analysis of Oncolytics Biotech help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Oncolytics from various momentum indicators to cycle indicators. When you analyze Oncolytics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About Oncolytics Biotech Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Oncolytics Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Oncolytics Biotech based on widely used predictive technical indicators. In general, we focus on analyzing Oncolytics Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Oncolytics Biotech's daily price indicators and compare them against related drivers, such as cycle indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Oncolytics Biotech's intrinsic value. In addition to deriving basic predictive indicators for Oncolytics Biotech, we also check how macroeconomic factors affect Oncolytics Biotech price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
2023 | 2024 (projected) | Net Debt To EBITDA | 0.92 | 1.57 | Intangibles To Total Assets | 0.0149 | 0.0141 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Oncolytics Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Align your values with your investing style
In addition to having Oncolytics Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.ESG Investing Invested few shares | ||
Hedge Favorites Invested few shares | ||
Business Services Invested over 100 shares | ||
Macroaxis Index Invested few shares | ||
Momentum Invested few shares | ||
Warren Buffett Holdings Invested over 40 shares | ||
Banking Invested over 20 shares | ||
Social Domain Invested over 90 shares | ||
Sports Invested over 90 shares | ||
Military Industrial Invested over 90 shares |
Additional Tools for Oncolytics Stock Analysis
When running Oncolytics Biotech's price analysis, check to measure Oncolytics Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncolytics Biotech is operating at the current time. Most of Oncolytics Biotech's value examination focuses on studying past and present price action to predict the probability of Oncolytics Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncolytics Biotech's price. Additionally, you may evaluate how the addition of Oncolytics Biotech to your portfolios can decrease your overall portfolio volatility.